The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Age-Related Macular Degeneration
Open accessAbstract
Age-related macular degeneration (AMD) is a leading cause of blindness. The main risk factor is advancing age, with the severity of vision loss ranging from mild to severe. There is a 25% risk of early AMD and 8% risk of late AMD in patients over the age of 75, with the number of cases expected to increase because of the aging population. Diagnosis of the disease requires a dilated fundus examination. Physicians should be aware of the symptoms, risk factors, and treatment options for AMD to refer appropriately for ophthalmologic evaluation. Early detection can be helpful to prevent disease progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wong, W. L., Su, X., Li, X., Cheung, C. M. G., Klein, R., Cheng, C.-Y., & Wong, T. Y. (2014) · The Lancet Global Health · doi:10.1016/s2214-109x(13)70145-1 · Cited by 5,331
Ranibizumab and bevacizumab for neovascular age-related macular degeneration
(2011) · New England Journal of Medicine · doi:10.1056/nejmoa1102673 · Cited by 2,669
Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration
Heier, J. S., Brown, D. M., Chong, V., Korobelnik, J.-F., Kaiser, P. K., Nguyen, Q. D., Kirchhof, B., Ho, A., Ogura, Y., Yancopoulos, G. D., et al. (2012) · Ophthalmology · doi:10.1016/j.ophtha.2012.09.006 · Cited by 2,485
Fritsche, L. G., Igl, W., Bailey, J. N. C., Grassmann, F., Sengupta, S., Bragg-Gresham, J. L., Burdon, K. P., Hebbring, S. J., Wen, C., Gorski, M., et al. (2016) · Nature Genetics · doi:10.1038/ng.3448 · Cited by 1,544
Age-related macular degeneration
Jager, R. D., Mieler, W. F., & Miller, J. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0801537 · Cited by 1,379 · cited 1×
“Argonlaser photocoagulation leads to regression of CNV with scar formation through the use of thermal energy to directly target neovascular lesions.(31) A limitation of focal laser is the occurrence of scotoma or permanent central vision loss in the treated area.”
BackgroundOptical Coherence Tomography: An Emerging Technology for Biomedical Imaging and Optical Biopsy
Fujimoto, J. G., Pitris, C., Boppart, S. A., & Brezinski, M. E. (2000) · Neoplasia · doi:10.1038/sj.neo.7900071 · Cited by 1,138
Age-Related Macular Degeneration and Blindness due to Neovascular Maculopathy
Ferris, F. L., Fine, S. L., & Hyman, L. (1984) · Archives of Ophthalmology · doi:10.1001/archopht.1984.01040031330019 · Cited by 1,093
Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis
Chakravarthy, U., Wong, T. Y., Fletcher, A., Piault, E., Evans, C., Zlateva, G., Buggage, R., Pleil, A., & Mitchell, P. (2010) · BMC Ophthalmology · doi:10.1186/1471-2415-10-31 · Cited by 842
A Simplified Severity Scale for Age-Related Macular Degeneration: AREDS Report No. 18
(2005) · Archives of Ophthalmology · doi:10.1001/archopht.123.11.1570 · Cited by 807
(2005) · Archives of Ophthalmology · doi:10.1001/archopht.123.11.1484 · Cited by 739
Maguire, M. G., Martin, D. F., Ying, G.-S., Jaffe, G. J., Daniel, E., Grunwald, J. E., Toth, C. A., Ferris, F. L., & Fine, S. L. (2016) · Ophthalmology · doi:10.1016/j.ophtha.2016.03.045 · Cited by 708
Fifteen-Year Cumulative Incidence of Age-Related Macular Degeneration
Klein, R., Klein, B. E. K., Knudtson, M. D., Meuer, S. M., Swift, M., & Gangnon, R. E. (2007) · Ophthalmology · doi:10.1016/j.ophtha.2006.10.040 · Cited by 638
Age‐related macular degeneration—emerging pathogenetic and therapeutic concepts
Gehrs, K. M., Anderson, D. H., Johnson, L. V., & Hageman, G. S. (2006) · Annals of Medicine · doi:10.1080/07853890600946724 · Cited by 631
The Retinal Pigment Epithelium in Health and Disease
R. Sparrrow, J., Hicks, D., & P. Hamel, C. (2010) · Current Molecular Medicine · doi:10.2174/156652410793937813 · Cited by 618
Age-Related Macular Degeneration: Genetics and Biology Coming Together
Fritsche, L. G., Fariss, R. N., Stambolian, D., Abecasis, G. R., Curcio, C. A., & Swaroop, A. (2014) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-090413-025610 · Cited by 534
Pennington, K. L., & DeAngelis, M. M. (2016) · Eye and Vision · doi:10.1186/s40662-016-0063-5 · Cited by 480
Seddon, J. M. (2006) · Archives of Ophthalmology · doi:10.1001/archopht.124.7.995 · Cited by 415
Klein, R., Klein, B. E. K., Tomany, S. C., Meuer, S. M., & Huang, G.-H. (2002) · Ophthalmology · doi:10.1016/s0161-6420(02)01146-6 · Cited by 363
Drusen in Age-Related Macular Degeneration
Abdelsalam, A., Del Priore, L., & Zarbin, M. A. (1999) · Survey of Ophthalmology · doi:10.1016/s0039-6257(99)00072-7 · Cited by 352
Age-Related Macular Degeneration and Smoking: The Rotterdam Study
Vingerling, J. R. (1996) · Archives of Ophthalmology · doi:10.1001/archopht.1996.01100140393005 · Cited by 246
Smoking and Age-Related Macular Degeneration: Review and Update
Velilla, S., García-Medina, J. J., García-Layana, A., Dolz-Marco, R., Pons-Vázquez, S., Pinazo-Durán, M. D., Gómez-Ulla, F., Arévalo, J. F., Díaz-Llopis, M., & Gallego-Pinazo, R. (2013) · Journal of Ophthalmology · doi:10.1155/2013/895147 · Cited by 221
Grunwald, J. E., Pistilli, M., Daniel, E., Ying, G.-S., Pan, W., Jaffe, G. J., Toth, C. A., Hagstrom, S. A., Maguire, M. G., & Martin, D. F. (2017) · Ophthalmology · doi:10.1016/j.ophtha.2016.09.012 · Cited by 214
Prevalence of age-related macular degeneration in Latinos
Varma, R., Fraser‐Bell, S., Tan, S., Klein, R., & Azen, S. P. (2004) · Ophthalmology · doi:10.1016/j.ophtha.2004.01.023 · Cited by 203
The Incidence and Progression of Age-Related Macular Degeneration over 15 Years
Joachim, N., Mitchell, P., Burlutsky, G., Kifley, A., & Wang, J. J. (2015) · Ophthalmology · doi:10.1016/j.ophtha.2015.08.002 · Cited by 199
Zhang, M., Yu, D., Yang, C., Xia, Q., Li, W., Liu, B., & Li, H. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9718-9 · Cited by 112
Update on depression and age-related macular degeneration
Casten, R. J., & Rovner, B. W. (2013) · Current Opinion in Ophthalmology · doi:10.1097/icu.0b013e32835f8e55 · Cited by 111
Daïen, V., Nguyen, V., Essex, R. W., Morlet, N., Barthelmes, D., Gillies, M. C., Gillies, M. C., Hunt, A., Essex, R. W., Dayajeewa, C., et al. (2017) · Ophthalmology · doi:10.1016/j.ophtha.2017.07.005 · Cited by 110
The Common Antidiabetic Drug Metformin Reduces Odds of Developing Age-Related Macular Degeneration
Brown, E. E., Ball, J. D., Chen, Z., Khurshid, G. S., Prosperi, M., & Ash, J. D. (2019) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.18-26422 · Cited by 107
Hanna, R. M., Barsoum, M., Arman, F., Selamet, U., Hasnain, H., & Kurtz, I. (2019) · Kidney International · doi:10.1016/j.kint.2019.02.042 · Cited by 106
Kiernan, D. F., Hariprasad, S. M., Rusu, I., Mehta, S., Mieler, W. F., & Jager, R. D. (2010) · Retina · doi:10.1097/iae.0b013e3181e2266d · Cited by 91
Bressler, N. M., Boyer, D. S., Williams, D. F., Butler, S. M., Francom, S. F., Brown, B., Nucci, F. D., Cramm, T., Tuomi, L. L., Ianchulev, T., et al. (2012) · Retina · doi:10.1097/iae.0b013e31825db6ba · Cited by 89
Maloney, M. H., Payne, S. R., Herrin, J. S., Sangaralingham, L. R., Shah, N. D., & Barkmeier, A. J. (2020) · Ophthalmology · doi:10.1016/j.ophtha.2020.07.062 · Cited by 88
Association between sunlight exposure and risk of age-related macular degeneration: a meta-analysis
Zhou, H., Zhang, H., AiQing, Y., & Xie, J. (2018) · BMC Ophthalmology · doi:10.1186/s12886-018-1004-y · Cited by 87
Current Evidence for the Prevention of Endophthalmitis in Anti-VEGF Intravitreal Injections
Lau, P. E., Jenkins, K. S., & Layton, C. J. (2018) · Journal of Ophthalmology · doi:10.1155/2018/8567912 · Cited by 86
Zarbin, M. A., Sugino, I. K., & Townes‐Anderson, E. (2019) · Stem Cells Translational Medicine · doi:10.1002/sctm.18-0282 · Cited by 84
Kitchens, J. W., Diana, V., Boyer, D. S., Thompson, D. E., Gibson, A., Saroj, N., Vitti, R., Berliner, A. J., & Kaiser, P. K. (2016) · Ophthalmology · doi:10.1016/j.ophtha.2016.02.046 · Cited by 68
Imaging in Neovascular Age-Related Macular Degeneration
Gess, A. J., Fung, A. E., & Rodriguez, J. G. (2011) · Seminars in Ophthalmology · doi:10.3109/08820538.2011.582533 · Cited by 54
Optical Coherence Tomographic Angiography Imaging in Age-Related Macular Degeneration
Ma, J., Desai, R. M., Nesper, P. L., et al. (2017) · Ophthalmology and Eye Diseases · doi:10.1177/1179172116686075 · Cited by 49
Gaudreault, J., Gunde, T., Floyd, H. S., Ellis, J., Tietz, J., Binggeli, D., Keller, B. C., Schmidt, A., & Escher, D. (2012) · Investigative Ophthalmology & Visual Science · Cited by 45
Evaluation of a Portable Artificial Vision Device Among Patients With Low Vision
Moisseiev, E., & Mannis, M. J. (2016) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2016.1000 · Cited by 39
Vascular endothelial growth factors and their inhibitors in ocular neovascular disorders.
Homayouni, M. (2009) · PubMed Central · Cited by 32
Current best clinical practices—management of neovascular AMD
Brown, D., Heier, J. S., Boyer, D. S., Freund, K. B., Kaiser, P., Kim, J. E., & Sarraf, D. (2017) · Journal of VitreoRetinal Diseases · doi:10.1177/2474126417725946 · Cited by 23 · cited 2×
“For wet AMD, anti-VEGF agents have proven to be beneficial in targeting CNV lesions and preserving vision.(34) VEGF is present throughout the body and required for normal angiogenesis.”
BackgroundAge-Related Macular Degeneration
Parmet, S., Lynm, C., & Glass, R. M. (2006) · JAMA · doi:10.1001/jama.295.20.2438 · Cited by 20
Zarbin, M. A., Francom, S. F., Grzeschik, S. M., Tuomi, L., Hašková, Z., Macfadden, W., Margaron, P., Snow, H., Cruess, A. F., Staurenghi, G., et al. (2018) · Ophthalmology Retina · doi:10.1016/j.oret.2018.04.018 · Cited by 15
Csaky, K. G., SCHACHAT, A. P., Kaiser, P. K., Small, K. W., & Heier, J. S. (2017) · Journal of VitreoRetinal Diseases · doi:10.1177/2474126416680671 · Cited by 8
Cited by
Oxidative stress in the eye and its role in the pathophysiology of ocular diseases
Böhm, E. W., Buonfiglio, F., Voigt, A. M., Bachmann, P., Safi, T., Pfeiffer, N., & Gericke, A. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102967 · Cited by 301
Nanotechnology-based ocular drug delivery systems: recent advances and future prospects
Li, S., Chen, L., & Fu, Y. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-01992-2 · Cited by 277
Metadata
- Authors
- Thomas, C. J., Mirza, R. G., & Gill, M. K.
- Venue
- Medical Clinics of North America
- Publisher
- Elsevier BV
- Published
- 2021-05
- Volume
- 105
- Issue
- 3
- Pages
- 473-491
- ISSN
- 0025-7125 (ISSN-L)
- OpenAlex
- W4211068092
- Cited by
- 399
- References
- 47
- FWCI
- 40.59
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.